Literature DB >> 6844122

Plasma levels of acetylsalicylic acid and salicylic acid after oral ingestion of plain and buffered acetylsalicylic acid in relation to bleeding time and thrombocyte function.

J H Proost, G W Van Imhoff, H Wesseling.   

Abstract

Buffered acetylsalicylic acid (Alka Seltzer, B-ASA) and plain aspirin (P-ASA) tablets were compared as to their effects on bleeding time and platelet function in eight healthy male volunteers. Two doses (500 and 1000 mg) of each preparation were investigated in a cross-over design, each volunteer being his own control in each dose group (n=4). Both preparations disturbed platelet aggregation to the same extent. Bleeding time increased after both preparations, though significantly more after the buffered preparation than after plain acetylsalicylic acid, irrespective of the dosage. The 1000 mg dose prolonged bleeding time significantly more than the 500 mg dose, irrespective of the preparation. Kinetic analysis showed that B-ASA gave higher peak plasma levels of acetylsalicylic acid (ASA) and accordingly salicylic acid peak levels were also higher after the buffered preparation. It is concluded that B-ASA in equi-analgesic doses prolongs bleeding time more than the plain preparation. Since it is less agressive on the gastro-intestinal mucosa, its use may be advantageous in situations where acetylsalicylic acid induced loss of platelet aggregation is desired. However, the risk of prolonged bleeding--e.g. after tooth extractions--is probably higher after the buffered preparation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6844122     DOI: 10.1007/bf01959647

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  9 in total

1.  Aspirin preperations and their noxious effect on the gastro-intestinal tract.

Authors:  L T STUBBE; J H PIETERSEN
Journal:  Br Med J       Date:  1962-03-10

2.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

3.  Effects of salicylates on human platelets.

Authors:  J R O'Brien
Journal:  Lancet       Date:  1968-04-13       Impact factor: 79.321

4.  Acetylsalicylic acid, bleeding time and age.

Authors:  K A Jørgensen; J Dyerberg; A S Olesen; E Stoffersen
Journal:  Thromb Res       Date:  1980-09-15       Impact factor: 3.944

5.  Kinetics of aspirin, salicylic acid, and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions.

Authors:  W D Mason; N Winer
Journal:  J Pharm Sci       Date:  1981-03       Impact factor: 3.534

6.  Effect of sodium bicarbonate on aspirin-induced damage and potential difference changes in human gastric mucosa.

Authors:  B K Bowen; W J Krause; K J Ivey
Journal:  Br Med J       Date:  1977-10-22

Review 7.  Hematologic perturbations associated with salicylate.

Authors:  B M Rothschild
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

8.  Salicylates and gastrointestinal bleeding. Acetylsalicylic acid and aspirin derivatives.

Authors:  P H WOOD; E A HARVEY-SMITH; A S DIXON
Journal:  Br Med J       Date:  1962-03-10

9.  Effect of aspirin and aspirin lysinate on platelet function in smokers and non-smokers.

Authors:  K T Morgan; F Duchosal; C Rogg; P A Miescher
Journal:  Acta Haematol       Date:  1980       Impact factor: 2.195

  9 in total
  9 in total

1.  An evaluation of different doses of soluble aspirin and aspirin tablets in postoperative dental pain.

Authors:  I S Holland; R A Seymour; R P Ward-Booth; R A Ord; K L Lim; R C Hoare
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

2.  Aspirin's Active Metabolite Salicylic Acid Targets High Mobility Group Box 1 to Modulate Inflammatory Responses.

Authors:  Hyong Woo Choi; Miaoying Tian; Fei Song; Emilie Venereau; Alessandro Preti; Sang-Wook Park; Keith Hamilton; G V T Swapna; Murli Manohar; Magali Moreau; Alessandra Agresti; Andrea Gorzanelli; Francesco De Marchis; Huang Wang; Marc Antonyak; Robert J Micikas; Daniel R Gentile; Richard A Cerione; Frank C Schroeder; Gaetano T Montelione; Marco E Bianchi; Daniel F Klessig
Journal:  Mol Med       Date:  2015-06-18       Impact factor: 6.354

3.  A comparative study of the effects of aspirin and paracetamol (acetaminophen) on platelet aggregation and bleeding time.

Authors:  R A Seymour; F M Williams; A Oxley; A Ward; M Fearns; K Brighan; M D Rawlins; P M Jones
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Comparative efficacy of soluble aspirin and aspirin tablets in postoperative dental pain.

Authors:  R A Seymour; F M Williams; N M Luyk; M A Boyle; P M Whitfield; E Nicholson; P W Booth; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 5.  Haematological effects of non-narcotic analgesics.

Authors:  P A Miescher; W Pola
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 6.  Multiple Targets of Salicylic Acid and Its Derivatives in Plants and Animals.

Authors:  Daniel F Klessig; Miaoying Tian; Hyong Woo Choi
Journal:  Front Immunol       Date:  2016-05-26       Impact factor: 7.561

7.  Effect of Health-Promoting Agents on Exclusion-Zone Size.

Authors:  Abha Sharma; Colby Adams; Benjamin D Cashdollar; Zheng Li; Nam V Nguyen; Himasri Sai; Jiachun Shi; Gautham Velchuru; Kevin Z Zhu; Gerald H Pollack
Journal:  Dose Response       Date:  2018-09-03       Impact factor: 2.658

8.  Human GAPDH Is a Target of Aspirin's Primary Metabolite Salicylic Acid and Its Derivatives.

Authors:  Hyong Woo Choi; Miaoying Tian; Murli Manohar; Maged M Harraz; Sang-Wook Park; Frank C Schroeder; Solomon H Snyder; Daniel F Klessig
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

9.  Effects of the cannabinoid CB1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs.

Authors:  Joel I Berger; Ben Coomber; Samantha Hill; Steve P H Alexander; William Owen; Alan R Palmer; Mark N Wallace
Journal:  Hear Res       Date:  2017-10-31       Impact factor: 3.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.